The news of the approval was tweeted by Mexico’s foreign minister Marcelo Ebrard. “Very timely decision by COFEPRIS to authorise the emergency use of the Covaxin vaccine manufactured in India. The options for vaccination against Covid-19 in Mexico are expanded,” said the post by Ebrard, a translated version of which was retweeted by the Twitter handle of the Indian Embassy in Mexico.
Covaxin now becomes the sixth Covid-19 vaccine to be approved in Mexico after Russia’s Sputnik V, the Pfizer & BioNTech vaccine, AstraZeneca-Oxford vaccine, Sinovac’s Coronavac and CanSino’s vaccine.
Mexico joins other countries like Zimbabwe, Nepal, Iran and Mauritius, among others, to have approved the use of the desi vaccine. The nod by the Mexican health regulator comes over a fortnight after neighbouring country Nepal granted emergency use approval to Covaxin and about a week after India shipped about 1 lakh doses of the vaccine to Paraguay. Covaxin doses have already been shipped to other countries like Iran and Mauritius under India’s `Vaccine Maitri’ programme.
While Brazil is yet to give its nod to Covaxin, it has already inked an agreement to procure 20 million doses of the vaccine, even as Ukraine and France are in parleys with Bharat Biotech. It has also inked a pact with US-based biopharma player Ocugen for Covaxin in the US market.